MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impact of manganese exposure on neurobehavioral disorders in rats: Insights into oxidative stress pathways and Parkinsonian syndrome pathophysiology

H. Harifi, H. Hami, L. Bikjdaouene (Kenitra, Morocco)

Meeting: 2025 International Congress

Keywords: Anxiety, Depression, Parkinsonism

Category: MSA, PSP, CBS: Pathophysiology / Molecular Mechanisms of Disease

Objective: This study investigates the correlation between oxidative stress in various neural structures induced by manganese (Mn) and the onset of anxious and depressive behaviours in rats.

Background: Manganese-induced Parkinson’s syndrome, resulting from exposure to manganese, is characterized by symptoms similar to those of Parkinson’s disease, including motor and non-motor disorders. Depression and anxiety in this syndrome may stem from both psychological shock and neurochemical dysfunctions, notably dopamine reduction in the striatum. The syndrome may also alter other brain regions involved in mood regulation.

Method: Three experimental groups of rats received MnCl2 injections at two doses (6 mg/kg and 25 mg/kg), and a control group received daily intraperitoneal injections of NaCl over 12 weeks. The rats’ weight was monitored weekly. Following the treatment period, the rats were subjected to a series of neurobehavioral tests prior to euthanasia to facilitate the extraction and analysis of oxidative stress levels in the prefrontal cortex, frontal cortex, hippocampus, and olfactory bulb.

Results: Neurobehavioral tests indicated that all rats treated with the highest dose of Mn (25 mg/kg) exhibited anxious and depressive behaviors, which correlated with significant increases in nitric oxide (NO), lipid peroxidation (LPO), and catalase levels in the studied structures. Conversely, the lowest dose of Mn (6 mg/kg) did not significantly increase these markers, correlating with the absence of anxious and depressive behaviors in 60% of this group.

Conclusion: Elevated levels of oxidative stress in the frontal cortex, prefrontal cortex, hippocampus, and olfactory bulb are associated with the development of anxious and depressive behaviors in rats, simulating a Parkinson’s-like syndrome. Additional neurochemical studies are recommended to explore the mechanisms underlying these observations further.

To cite this abstract in AMA style:

H. Harifi, H. Hami, L. Bikjdaouene. Impact of manganese exposure on neurobehavioral disorders in rats: Insights into oxidative stress pathways and Parkinsonian syndrome pathophysiology [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/impact-of-manganese-exposure-on-neurobehavioral-disorders-in-rats-insights-into-oxidative-stress-pathways-and-parkinsonian-syndrome-pathophysiology/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/impact-of-manganese-exposure-on-neurobehavioral-disorders-in-rats-insights-into-oxidative-stress-pathways-and-parkinsonian-syndrome-pathophysiology/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley